Stay updated on Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A new Locations section is added showing the Chicago, Illinois site; the standalone Illinois Locations entry was removed, and the revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T17:09:46.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Two timestamp labels in the Study Record Dates area were updated to include (Estimated), changing Results First Posted (Estimated) and Last Update Posted (Estimated). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-16T03:44:31.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Study status updated to Terminated due to drug supply no longer available. Results for primary and secondary outcomes have been posted.
    Difference
    2%
    Check dated 2025-12-09T00:37:03.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page revision history has been updated: Revision: v3.3.2 was added and Revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:59:46.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now displays a 'Results Submitted' indicator, and the 'No Results Posted' and the government funding status notices were removed.
    Difference
    0.5%
    Check dated 2025-11-17T17:51:50.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page; the study details and layout appear the same as before.
    Difference
    0.4%
    Check dated 2025-11-03T12:31:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial page.